For InvestorsAntares Pharma: Making Medicines Feel Better

Recent News

Information contained in these press releases should be considered accurate only as of the date it was prepared. Information may change over time. Do not assume that the information remains accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

10 Dec 2019
Antares Pharma Appoints Edward Tykot Senior Vice President, Corporate Development

06 Dec 2019
Antares Pharma Social Media Campaign for XYOSTED® Wins Marcom Platinum Award

27 Nov 2019
Antares Pharma To Present At The 31st Annual Piper Jaffray Healthcare Conference

19 Nov 2019
Antares Pharma Enters Into a Global Development Agreement with Idorsia Pharmaceuticals Ltd.

13 Nov 2019
Antares Pharma To Present at the Jefferies 2019 London Healthcare Conference

05 Nov 2019
Antares Pharma Reports Third Quarter 2019 Operating and Financial Results

31 Oct 2019
Antares Pharma Announces Receipt of Final Payment from Sale of Zomajet™ Needle-Free Delivery System

29 Oct 2019
Antares Pharma to Report Third Quarter 2019 Financial and Operating Results

24 Oct 2019
Antares Pharma Announces Two Poster Presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting

17 Sep 2019
Antares Pharma To Present at the Ladenburg Thalmann 2019 Healthcare Conference

20 Aug 2019
Antares Pharma partner Teva Pharmaceuticals issued a press release dated August 20,2019, relating to our partnership with Teva on the generic Epipen Jr.® - read the news regarding product availability.

06 Aug 2019
Antares Pharma Reports Second Quarter 2019 Operating and Financial Results

30 Jul 2019
Antares Pharma To Report Second Quarter 2019 Financial and Operating Results

27 Jun 2019
Antares Pharma Announces Amendment To Existing Loan And Security Agreement With Hercules Capital

30 May 2019
Antares Pharma to Present at the Jefferies 2019 Healthcare Conference

16 May 2019
Antares Pharma to Present at the B.Riley FBR Institutional Investor Conference

02 May 2019
Antares Pharma Reports First Quarter 2019 Operating and Financial Results

18 Apr 2019
Antares Pharma to Report First Quarter 2019 Financial and Operating Results

28 Mar 2019
Antares Pharma Announces Receipt of Orphan Drug Designation For The Treatment of Ectopic Pregnancy With Methotrexate

04 Mar 2019
Dr. Karen Smith joins the Antares board

28 Feb 2019
ANTARES PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2018 OPERATING AND FINANCIAL RESULTS

28 Feb 2019
Antares Pharma Reports Fourth Quarter And Full Year 2018 Operating and Financial Results

27 Feb 2019
Antares Pharma to Present at the Raymond James & Associates 40TH Annual Institutional Investors Conference

For Investors

Press Release Archive



Sign up for breaking news on ATRS

* indicates required